MicroGenDX, the world leader in providing Next Generation DNA Sequencing (NGS) in microbial identification, processed samples in the groundbreaking study “Next Generation Sequencing for the Diagnosis of Periprosthetic Knee Infection: A Multicenter Investigation” led by the Rothman Institute. The study recently accepted the Eastern Orthopaedic Association’s Musculoskeletal Infection Award and further evidenced that advanced molecular diagnostic testing gives hope to patients suffering from devastating chronic infections.
